Your at­ten­tion, please: As­traZeneca asks for a mo­ment of rapt si­lence, for a BLA ac­cep­tance?

As­traZeneca $AZN made an odd move this morn­ing for a Big Phar­ma com­pa­ny. It halt­ed trad­ing in its shares to an­nounce that the FDA has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.